BDSX
Biodesix Inc
NASDAQ: BDSX · HEALTHCARE · DIAGNOSTICS & RESEARCH
$15.32
-0.97% today
Updated 2026-05-08
Market cap
$113.91M
P/E ratio
—
P/S ratio
1.29x
EPS (TTM)
$-4.75
Dividend yield
—
52W range
$3 – $20
Volume
0.1M
Biodesix Inc (BDSX) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-17.68M | $-21.73M | $-21.37M | $-28.22M | $-44.97M | $-22.87M | $-48.65M | $-23.27M |
| Capital expenditures | $617000.00 | $1.31M | $2.18M | $2.55M | $3.53M | $23.06M | $3.23M | $403000.00 |
| Depreciation | — | — | — | — | — | — | — | — |
| Stock-based comp | $142000.00 | $170000.00 | $3.71M | $4.94M | $5.96M | $5.37M | $6.64M | $4.14M |
| Free cash flow | $-18.29M | $-23.04M | $-23.54M | $-30.77M | $-48.51M | $-45.93M | $-51.88M | $-23.67M |
| Investing cash flow | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | $328000.00 | — | $643000.00 | — | — |
| Share repurchases | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — |